Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 7/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 6/20 | 0.40 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1782208 | 0.93 | ACE2 (0.53) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL13177054 | 0.93 | ACE2 (0.53) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL17104323 | 0.91 | ACE2 (0.57) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL13480159 | 0.91 | ACE2 (0.57) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL13176543 | 0.91 | ACE2 (0.57) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL1783969 | 0.91 | ACE2 (0.57) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL12446359 | 0.91 | ACE2 (0.57) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL2637623 | 0.89 | ACE2 (0.55) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL2637624 | 0.89 | ACE2 (0.55) | ALDH1A1TDP1ACE2CA2CA1 | |
| SCHEMBL594273 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110511721-A | A kind of display fitting special-purpose organic silicon adhesive and preparation method thereof | UNIV FUDAN | 2019-11-29 | — | — | CN | claimed |
| US-RE46318-E1 | Colored fluids for electrowetting, electrofluidic, and electrophoretic technologies | SUN CHEMICAL CORPORATION (US) | 2017-02-21 | — | — | US | claimed |
| US-8717663-B2 | Colored fluids for electrowetting, electrofluidic, and electrophoretic technologies | SUN CHEMICAL CORPORATION (US) | 2014-05-06 | — | — | US | claimed |
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-24 | — | — | US | disclosed |
| US-12222653-B2 | Method for forming semiconductor structure | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-02-11 | — | — | US | disclosed |
| US-20250000088-A1 | ANT CONTROL AGENT AND ANT CONTROL METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-01-02 | — | — | US | disclosed |
| EP-4424164-A1 | ANT CONTROL AGENT AND ANT CONTROL METHOD | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-09-04 | — | — | EP | disclosed |
| CN-118139527-A | Ant control agent and ant control method | 信越化学工业株式会社 | 2024-06-04 | — | — | CN | disclosed |
| CN-111417373-B | Hair dyeing composition comprising microcapsules | 弗门尼舍有限公司 | 2024-04-12 | — | — | CN | disclosed |
| US-20230272239-A1 | LIQUID COMPOSITION, LIQUID COMPOSITION FOR INKJET DISCHARGING, DEVICE FOR MANUFACTURING LAYER CONTAINING INORGANIC OXIDE, METHOD OF MANUFACTURING LAYER CONTAINING INORGANIC OXIDE, AND ELECTROCHEMICAL DEVICE | RICOH COMPANY, LTD. (JP) | 2023-08-31 | — | — | US | disclosed |
| EP-4235833-A1 | LIQUID COMPOSITION, LIQUID COMPOSITION FOR INKJET DISCHARGING, DEVICE FOR MANUFACTURING LAYER CONTAINING INORGANIC OXIDE, METHOD OF MANUFACTURING LAYER CONTAINING INORGANIC OXIDE, AND ELECTROCHEMICAL DEVICE | Ricoh Company, Ltd. (JP) | 2023-08-30 | — | — | EP | disclosed |
| US-20030008863-A1 | Novel tricyclic diazepines tocolytic oxytocin receptor antagonists | WYETH | 2003-01-09 | — | — | US | disclosed |
| US-6476011-B1 | Methods for introducing an estrogenic compound | STERIX LIMITED (GB) | 2002-11-05 | — | — | US | disclosed |
| CN-1376057-A | Anti-virus composition | JANSSEN PHARMACEUTICA NV (BE) | 2002-10-23 | — | — | CN | disclosed |
| US-6307064-B1 | PHENYLISOSERINE ESTER OF SILYLATED BACCATIN III | PHARMACIA & UPJOHN COMPANY | 2001-10-23 | — | — | US | disclosed |
| US-6214844-B1 | ANTIARTHRITIC AGENTS; BONE DISORDERS; ANTIINFLAMMATORY AGENTS | SMITHKLINE BEECHAM CORPORATION | 2001-04-10 | — | — | US | disclosed |
| US-6075011-A | 6-O-substituted erythromycin compounds and method for making same | ABBOTT LABORATORIES (US) | 2000-06-13 | — | — | US | disclosed |
| EP-0910567-A1 | TRICYCLIC IBOGAINE ANALOGS, THEIR PREPARATION AND THEIR USE IN TREATING SUBSTANCE ABUSE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1999-04-28 | — | — | EP | disclosed |
| WO-1997020847-A1 | TRICYCLIC IBOGAINE ANALOGS, THEIR PREPARATION AND THEIR USE IN TREATING SUBSTANCE ABUSE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1997-06-12 | — | — | WO | disclosed |
| EP-0176161-A1 | Novel fluoran compounds and production and use thereof | TAOKA CHEMICAL CO., LTD (JP) | 1986-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | URB2, UQCRB, UQCRC2 | ALDH1A1 1357/4885TDP1 4236/4885ACE2 1094/4885 |
| US-20030008863-A1 | Novel tricyclic diazepines tocolytic oxytocin receptor antagonists | OXTR, OPRL1, HCRTR2 | ALDH1A1 3354/4885TDP1 1218/4885ACE2 1637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.